Ron Feld

673 total citations
9 papers, 510 citations indexed

About

Ron Feld is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Ron Feld has authored 9 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Ron Feld's work include Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Occupational and environmental lung diseases (2 papers). Ron Feld is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Occupational and environmental lung diseases (2 papers). Ron Feld collaborates with scholars based in Canada, New Zealand and United States. Ron Feld's co-authors include Jennifer J. Knox, Malcolm J. Moore, Lillian L. Siu, David W. Hedley, Amit M. Oza, Eric X. Chen, Gregory R. Pond, Marc de Perrot, William K. Evans and Masaki Anraku and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Thoracic Oncology.

In The Last Decade

Ron Feld

9 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron Feld Canada 7 317 252 228 102 49 9 510
Saburo Nakashima Japan 13 281 0.9× 229 0.9× 234 1.0× 179 1.8× 8 0.2× 26 554
Takuo Takehana Japan 7 224 0.7× 338 1.3× 81 0.4× 140 1.4× 10 0.2× 14 478
Akihiro Kitaoka Japan 9 141 0.4× 162 0.6× 140 0.6× 207 2.0× 14 0.3× 21 431
He-San Luo China 12 151 0.5× 158 0.6× 162 0.7× 194 1.9× 17 0.3× 24 450
Mitsuhiko Hanawa Japan 5 259 0.8× 281 1.1× 114 0.5× 187 1.8× 8 0.2× 8 477
T. S. Tzai Taiwan 7 74 0.2× 143 0.6× 153 0.7× 142 1.4× 11 0.2× 14 381
Masaki Mori Japan 11 120 0.4× 117 0.5× 165 0.7× 151 1.5× 13 0.3× 15 393
Adam G. Baseman United States 7 149 0.5× 129 0.5× 105 0.5× 163 1.6× 23 0.5× 8 423
Makiko Yasumoto Japan 12 89 0.3× 146 0.6× 177 0.8× 211 2.1× 33 0.7× 36 461
Inge Ubink Netherlands 14 86 0.3× 241 1.0× 139 0.6× 145 1.4× 13 0.3× 19 459

Countries citing papers authored by Ron Feld

Since Specialization
Citations

This map shows the geographic impact of Ron Feld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Feld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Feld more than expected).

Fields of papers citing papers by Ron Feld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Feld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Feld. The network helps show where Ron Feld may publish in the future.

Co-authorship network of co-authors of Ron Feld

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Feld. A scholar is included among the top collaborators of Ron Feld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Feld. Ron Feld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Wu, Licun, Ghassan Allo, Thomas John, et al.. (2016). Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma. Clinical Cancer Research. 23(4). 1060–1067. 40 indexed citations
2.
Cho, John, Ron Feld, Natasha B. Leighl, et al.. (2014). A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy: The “SMART” Approach for Resectable Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 9(3). 397–402. 85 indexed citations
3.
Knox, Jennifer J., Sharlene Gill, Timothy W. Synold, et al.. (2008). A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168). Investigational New Drugs. 26(3). 265–272. 55 indexed citations
4.
Feld, Ron, Srikala S. Sridhar, Frances A. Shepherd, Jean A. Mackay, & William K. Evans. (2006). Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib and Erlotinib in the Treatment of Non-small Cell Lung Cancer: A Systematic Review. Journal of Thoracic Oncology. 1(4). 367–376. 38 indexed citations
5.
Feld, Ron, Srikala S. Sridhar, Frances A. Shepherd, Jean A. Mackay, & William K. Evans. (2006). Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib and Erlotinib in the Treatment of Non-small Cell Lung Cancer: A Systematic Review. Journal of Thoracic Oncology. 1(4). 367–376. 21 indexed citations
6.
Knox, Jennifer J., David W. Hedley, Amit M. Oza, et al.. (2005). Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial. Journal of Clinical Oncology. 23(10). 2332–2338. 242 indexed citations
7.
8.
Moore, Malcolm J., Ron Feld, David W. Hedley, Amit M. Oza, & Lillian L. Siu. (1998). A phase II study of Temozolomide in advanced untreated pancreatic cancer. Investigational New Drugs. 16(1). 77–79. 22 indexed citations
9.
Moore, Malcolm J., Leonard Kaizer, Charles Erlichman, et al.. (1995). A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal caner. Cancer Chemotherapy and Pharmacology. 37(1-2). 86–90. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saburo Nakashima Breakdown of academic impact, for papers by Takuo Takehana Breakdown of academic impact, for papers by Akihiro Kitaoka Breakdown of academic impact, for papers by He-San Luo Breakdown of academic impact, for papers by Mitsuhiko Hanawa Breakdown of academic impact, for papers by T. S. Tzai Breakdown of academic impact, for papers by Masaki Mori Breakdown of academic impact, for papers by Adam G. Baseman Breakdown of academic impact, for papers by Makiko Yasumoto Breakdown of academic impact, for papers by Inge Ubink
Rankless by CCL
2026